Trial Profile
A phase II trial of high dose cytarabine and fludarabine without anthracycline for patients with core binding factor acute myeloid leukaemia, measuring efficacy, safety and monitoring minimal residual disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2017
Price :
$35
*
At a glance
- Drugs Fludarabine (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 16 Aug 2017 Status changed from active, no longer recruiting to completed.
- 23 Jun 2011 New trial record